Source:http://linkedlifedata.com/resource/pubmed/id/16471316
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-2-13
|
pubmed:abstractText |
In the present study, we report results of 28 rectal cancer patients, aged 70 years and older, treated with preoperative radiotherapy and 5FU concomitant chemotherapy. Twenty-eight out of 136 patients treated in our Department between 1997 and 2004 aged > or = 70 years, mean 73 (range 70-81); 3 T2, 18 T3, 7 T4; 15 N0, 5N1, 8 N2; Radiotherapy (5040 cGy, 28 fractions) was delivered combined with 5FU - based concomitant chemotherapy. Compliance to chemoradiotherapy was excellent. Major acute toxicity (> or = G3) evaluation showed haematological Grade 3 only in 2 patients. No severe acute Gastrointestinal toxicity was observed. All patients underwent surgery without severe perioperative complications. Complete pathological response pT0 was found in 3 patients (11%). Overall T downstaging occurred in 61% of the cases. Mean follow up was 34 months (range 4- 84). Kaplan Meier Overall Survival and Disease Free Survival at 5 years were 74% (95% CI 54 -95) and 65% (95% CI 38-93), respectively. Only 1 patient showed G3 diarrhea according to CTCAE that interfered with his Quality of Life and required hospitalization. In conclusion, concomitant radiochemotherapy 5FU based is safe in rectal cancer patients aged > or = 70 with a good tumour downstaging (61% of patients) and excellent feasibility. No treatment related death was observed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0392-9078
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
541-6
|
pubmed:meshHeading |
pubmed-meshheading:16471316-Aged,
pubmed-meshheading:16471316-Aged, 80 and over,
pubmed-meshheading:16471316-Antineoplastic Agents,
pubmed-meshheading:16471316-Chemotherapy, Adjuvant,
pubmed-meshheading:16471316-Colorectal Neoplasms,
pubmed-meshheading:16471316-Combined Modality Therapy,
pubmed-meshheading:16471316-Disease-Free Survival,
pubmed-meshheading:16471316-Humans,
pubmed-meshheading:16471316-Neoadjuvant Therapy,
pubmed-meshheading:16471316-Radiotherapy, Adjuvant,
pubmed-meshheading:16471316-Survival Analysis
|
pubmed:year |
2005
|
pubmed:articleTitle |
Feasibility of preoperative chemoradiation in rectal cancer patients aged 70 and older.
|
pubmed:affiliation |
Dept. of Oncology and Radiotherapy, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy. gio@mobilia.it
|
pubmed:publicationType |
Journal Article
|